drugset / Trial / NCT05802329
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Timeline
- Start
- 2024-01-13
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OCU200 | Unknown | 0.5 mg/ml | Intravitreal |
| Subject | OCU200 | Unknown | 1 mg/ml | Intravitreal |
| Subject | OCU200 | Unknown | 2 mg/ml | Intravitreal |
| Subject | OCU200 | Unknown | 5 mg/ml | Intravitreal |